Stratec SE (Stratec SE) FCF Margin % : -3.69% (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Stratec SE FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Stratec SE's Free Cash Flow for the three months ended in Mar. 2024 was $-2.04 Mil. Stratec SE's Revenue for the three months ended in Mar. 2024 was $55.30 Mil. Therefore, Stratec SE's FCF Margin % for the quarter that ended in Mar. 2024 was -3.69%.

As of today, Stratec SE's current FCF Yield % is -0.13%.

The historical rank and industry rank for Stratec SE's FCF Margin % or its related term are showing as below:

During the past 13 years, the highest FCF Margin % of Stratec SE was 22.82%. The lowest was -3.99%. And the median was 2.95%.

SBMDY's FCF Margin % is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: -7.38
* Ranked among companies with meaningful FCF Margin % only.

Stratec SE FCF Margin % Historical Data

The historical data trend for Stratec SE's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stratec SE FCF Margin % Chart

Stratec SE Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-2.61

2.51

15.05

-3.18

0.76

Stratec SE Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															1.40	-9.05	2.74	7.11	-3.69

Competitive Comparison of Stratec SE's FCF Margin %

For the Medical Devices subindustry, Stratec SE's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stratec SE's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stratec SE's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Stratec SE's FCF Margin % falls into.

Stratec SE FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Stratec SE's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	2.182	/	285.617
	=	0.76 %

Stratec SE's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-2.038	/	55.295
	=	-3.69 %

Stratec SE FCF Margin % Related Terms

Thank you for viewing the detailed overview of Stratec SE's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Stratec SE (Stratec SE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stratec SE (OTCPK:SBMDY) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

SBS:Germany

Address

Gewerbestrasse 37, Birkenfeld, RP, DEU, 75217

Website

https://www.stratec.com

Stratec SE designs and manufactures automated analyzer systems for laboratory data management and solutions for molecular diagnostic sample preparation and stabilization. Its business segments are Instrumentation, Diatron and Smart Consumables. Its Instrumentation segment is engaged in designing and manufacturing automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment comprises the business with systems, system components, consumables, and tests in the low throughput hematology and clinical chemistry segment. Its Smart Consumables segment is engaged in developing and selling scientific materials, such as nucleic acid purification. The company generates maximum revenue from the Instrumentation segment.

Stratec SE (Stratec SE) Headlines

From GuruFocus

STRATEC SE: STRATEC Further Expands Its Presence in USA By Acquiring Natech Plastics

By ACCESSWIRE ACCESSWIRE • 06-07-2023